Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pareto Securities AB and Swedbank AB (publ) in connection with a bond issue with a framework amount of up to MSEK 700
Mandate

Vinge has advised Pareto Securities AB and Swedbank AB (publ) in connection with a bond issue with a framework amount of up to MSEK 700

December 18, 2017 Banking and Finance

Vinge has advised Pareto Securities AB and Swedbank AB (publ) in connection with a bond issue with a framework amount of up to MSEK 700 senior unsecured floating rate bonds, issued by Offentliga Hus i Norden AB (publ) (”Offentliga Hus”) on 15 December 2017.

Pareto Securities AB and Swedbank AB (publ) have acted as arrangers and Swedbank AB (publ) also acted as issuing agent. The bonds have a tenor of three and a half years and a floating interest rate of three-months STIBOR plus a margin of 7.00 per cent.
 
The proceeds from the bond issue will be applied towards financing property acquisitions and other general corporate purposes. Offentliga Hus intends to apply for the bonds to be listed on Nasdaq Stockholm.
 
Vinges team consisted inter alia of Louise Brorsson Salomon, Lionardo Ojeda and Sara Osman.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025